TGFB3 and neoplasm: The first of these estrogen-regulated markers, pS2, is a well-established marker of ER activation (Krieg et al., 2004); the second, TGFβ3, allows evaluating cellular differentiation and tumor suppressive mechanisms (Liu et al., 2021).